US 12215316
Materials and methods for treatment of usher syndrome type 2A
granted A61PA61P27/00
Quick answer
US patent 12215316 (Materials and methods for treatment of usher syndrome type 2A) held by CRISPR THERAPEUTICS AG expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P27/00